News is coming 100%
Eric presentation yesterday to the US market was very good.
Confirmation of phase 1/11 trails
First in human in 18 months
More patents to follow
Meeting with European health authorities on Monday 26th June
Meeting with FDA to follow European meeting
Also I’m conversations with veterinary companies re dog longevity and selling the model to them to fund more growth through none dilution.
Not a share to be selling in my opinion. Get in early sit, and patience will pay off
GLA
first interaction with ***g, european health authorities on june 26th 2023!!
Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum. Individual investors, institutional investors, advisors, and analysts are invited to attend.
REGISTER NOW AT: https://bit.ly/3p8LhIP
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1x1 meetings with management.
“We’re looking forward to bringing together innovators from the life sciences sector this Thursday,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “This Virtual Investor Conference will provide an efficient platform for these companies to seamlessly engage and broaden their investor base.”
June 22nd
Eastern
Time (ET) Presentation Ticker(s)
9:30 AM Orexo AB OTCQX: ORXOY | STO: ORX
10:00 AM StarPharma Holdings Limited OTCQX: SPHRY | ASX: SPL
10:30 AM Medinotec Inc. OTCQX: MDNC
11:00 AM ReShape Lifesciences Inc. NASDAQ: RSLS
11:30 AM NervGen Pharma Corp. OTCQX: NGENF | TSXV: NGEN
12:00 PM Genflow Biosciences PLC OTCQB: GENFF | LSE: GENF
12:30 PM Else Nutrition Holdings Inc. OTCQX: BABYF | TSX: BABY
1:00 PM PharmAla Biotech Holdings Inc. Pink: PMBHF | CSE: MDMA
1:30 PM Alpha Cognition Inc. OTCQB: ACOGF | CSE: ACOG
2:00 PM Kiora Pharmaceuticals, Inc. NASDAQ: KPRX
To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
Just think when they do start buying at $0.10/7.9p the rerate upto that will be lovely. Hopefully see another strong day.
GLA
I would say at least 500k. No way of knowing for sure what they have tho just now
There had to be 500k shares stateside for todays listing. Huge spread of 90%. 0.10c to buy which is about 7.9p! Need to get the mm buying and there’s a huge gap up in play
3 MM’s currently showing in the US nothing traded as of yet
Key take away
As the Company moves into Phase I/II clinical trials to treat potentially the orphan condition Werner Syndrome, which causes premature aging, and NASH, a liver disease that affects an estimated 35 million people around the world, it is the right time to retain our London Stock Exchange listing while adding easier access for US investors."
Great to hear we are into clinical trials also!!!
Can’t see there being a buyout at least for another 2/3 years
Hope so Merlin
GLA
Between 14/28th June going off the otcqb 8-10 week time line. Could be sooner tho
Hold for gold. Our time will come
Great buying opportunity this
Swanny you must be on for a TR1 soon
Fantastic RNS yet again by Eric. Further strengthening his team. The promotion of Vera Gorbunova PhD is a master stroke! GLA
Yes the US is the key market here. Hopefully will lead to a lot more exposure and none diluting grants ect. Also not long until the European Health agency meeting with Eric in Belgium early June. Game changing times ahead.
Hey Dave,
3 weeks on Wednesday since application RNS. We Where told 8 weeks max which is 5 left. Funny feeling the application was done well before the RNS tho. Could be a lot sooner.
GL
Before the Rip
We are away to list in a country that actually gets what we do. Will see 10p before 2p again